Cambrex

Cambrex will be attending MEDevice in Boston this fall. Mark your calendar for September 25-26 at the Boston Convention & Exhibition Center. Click the link to schedule a meeting: https://lnkd.in/ga6nfGnC #MEDeviceBoston #ConnectWithCambrex 

Don't miss this third annual Stability Studies Conference hosted by Q1 Scientific taking place October 17th just outside of Dublin, Ireland. This event brings together industry experts sharing their insights on the latest trends and best practices in stability studies and product development. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝗮𝗻𝗱 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁: https://lnkd.in/gdPQZHGE

Extractables and leachables (“E&L”) studies are an essential component of regulatory filing to demonstrate product safety. Depending on the container-closure system or medical device being evaluated, E&L studies can be very complex. Choosing a CDMO with expertise is critical to successful delivery of robust E&L data that you can trust. Read our whitepaper to learn more about the criticality of E&L studies when it comes to patient safety and how Cambrex’s analytical services offerings can help address your program needs. https://lnkd.in/g6z66Drd #EandL #Pharma #AnalyticalTesting #CDMO

#CPHIMilan 2024 is quickly approaching. Both the Cambrex and Snapdragon Chemistry teams are looking forward to meeting you in Milano, Italy! Click the link to schedule a meeting 8-10 October at stand # 5B1: https://lnkd.in/gj28bNA3 #CPHI #AtTheHeartOfPharma #CDMO #Pharma #Manufacturing #PharmaceuticalIndustry

Attending American Chemical Society's National Fall Meeting in Denver, CO next week? Don't miss the opportunity to hear from our Snapdragon Chemistry #ContinuousFlow experts. 

Cambrex is excited to be back at Nordic Life Science Days next month. The Cambrex team is looking forward to meeting you face-to-face in Malmö! Click the link to schedule a meeting -> Hamid Parsa and Gianluca Di Lernia -> https://lnkd.in/eQZCUqYM #NLSdays #CDMO #ConnectWithCambrex

We're thrilled to be part of American Chemical Society's National Fall Meeting in Denver, CO next week. You don't want to miss these sessions: "Addressing Solvent Limitations and Exothermic Character of Nitroarene Reduction by Diboron Reagents" | August 18, 7:00 PM - 9:00 PM; Poster 4105493 “Expanding Scope and Application of Chemoselective Aromatic Nitro Reductions by Tetrahydroxydiboron” | August 18, 7:00 PM - 9:00 PM; Poster 4106042 “Understanding the Drug Development Process, Life Cycle, and Project Team in the Transition from Discovery to Early Chemical Development: The Nuts and Bolts of IND-Enabling Research” | August 18, 7:00 PM - 9:00 PM; Poster 4109668 “Process Development and Kilogram-scale Demonstration of Nitroarene Reduction by Tetrahydroxydiboron” | August 19, 8:00 PM - 10:00 PM; Poster 4106081 “Accelerating Phase-Appropriate Drug Substance (API) Development: A Case Study Review of Strategic Decisions, Pitfalls and Science Behind Early Phase Development” | August 20, 4:35 PM - 5:00 PM Presented by: Aliakbar Mohammadlou, PhD, Amber Rydholm, Ph.D., Amy Taylor, Bradley Rose, Cy Credille, Derek Burnet M.S., Derrick Juengst, James Graham, Kerrick C. Rees, PhD, Kimberly Casalvieri, Matthew Haynes, Morris Dweck, Saeedeh Torabi Kohlbouni, Sara F., Tracy Milburn #ACSFall2024 #CDMO #ConnectWithCambrex

Attending ChemOutsourcing next month? Connect with the Cambrex team at the Parsippany Hilton throughout #ChemOutsourcing Week. Click the link to schedule a meeting -> Mark Eugenio, Michael Mrvos, and Jason Blanchard -> https://lnkd.in/gdW2buyw #CDMO #ConnectWithCambrex 

Continuous chemical manufacturing technology has been in use for more than 100 years producing high-volume commodity chemicals. However, it was not until the early 2000s that the technology caught the attention of the pharmaceutical industry in a significant way, and it has since revolutionized the production of pharmaceuticals. In our recent article published in European Pharmaceutical Review, Matthew Bio, Chief Scientific Officer at Cambrex, discusses how continuous manufacturing has become integral to the pharmaceutical industry. Read the full article here: https://lnkd.in/eBp4nxn2

Peptide crystallization introduces greater complexity due to molecular flexibility and size. Each peptide requires unique insight to optimize individual conditions. Trust the team at Cambrex to deliver reliable, scalable results. We leverage the right tools with the best experts to bridge success from the bench to the plant. Learn more here: https://lnkd.in/gbn7K3t5 #peptides #crystallization #pharma